Martin W. King
(North Carolina State University, USA)

Martin King joined the Wilson College of Textiles, North Carolina State University, as Professor of Biotextiles and Textile Technology in September 2000 following more than 30 years of experience working in industry, higher education, the healthcare and government sectors in Canada and Europe. After graduating in Polymer Technology from UMIST, Manchester, England, and receiving his PhD in Biomedical Engineering (Génie biologique) from l’Université de Technologie de Compiègne, France, he has worked as a product development engineer for Hoechst-Celanese in Canada and at the British Ministry of Technology developing novel carbon fibers for the reinforcement of plastic components in Rolls-Royce jet engines.
For over 40 years Martin King has pioneered research at the intersection of biomaterials, fiber and polymer science and textile engineering. Since 1972 he has been a faculty member at the University of Manitoba, Canada where he coined the term “Biotextiles” to refer to fiber-based implantable medical devices. During his academic career he has been a consultant with all the major medical device companies in the USA, and has been invited to establish biomedical textile laboratories in various countries around the globe. In 1981-83 he helped establish the Quebec Biomaterials Institute in le Département de Chirurgie (Department of Surgery) at Université Laval, Québec, Canada. Then in 2000 he was recruited to establish the first ever undergraduate university program in “Medical Textiles” at the Wilson College of Textiles at North Carolina State University. In 2005 he was appointed as the “Chaired Professor of Medical Textiles”, and the only non-Chinese faculty member, at Donghua University, Shanghai, China. More recently his unique expertise has been recognized in Ecuador and Pakistan where he has been invited to establish new university curricula and laboratory facilities for biomedical textile teaching and research.

Martin W. King
(North Carolina State University, USA)

Martin King joined the Wilson College of Textiles, North Carolina State University, as Professor of Biotextiles and Textile Technology in September 2000 following more than 30 years of experience working in industry, higher education, the healthcare and government sectors in Canada and Europe. After graduating in Polymer Technology from UMIST, Manchester, England, and receiving his PhD in Biomedical Engineering (Génie biologique) from l’Université de Technologie de Compiègne, France, he has worked as a product development engineer for Hoechst-Celanese in Canada and at the British Ministry of Technology developing novel carbon fibers for the reinforcement of plastic components in Rolls-Royce jet engines.
For over 40 years Martin King has pioneered research at the intersection of biomaterials, fiber and polymer science and textile engineering. Since 1972 he has been a faculty member at the University of Manitoba, Canada where he coined the term “Biotextiles” to refer to fiber-based implantable medical devices. During his academic career he has been a consultant with all the major medical device companies in the USA, and has been invited to establish biomedical textile laboratories in various countries around the globe. In 1981-83 he helped establish the Quebec Biomaterials Institute in le Département de Chirurgie (Department of Surgery) at Université Laval, Québec, Canada. Then in 2000 he was recruited to establish the first ever undergraduate university program in “Medical Textiles” at the Wilson College of Textiles at North Carolina State University. In 2005 he was appointed as the “Chaired Professor of Medical Textiles”, and the only non-Chinese faculty member, at Donghua University, Shanghai, China. More recently his unique expertise has been recognized in Ecuador and Pakistan where he has been invited to establish new university curricula and laboratory facilities for biomedical textile teaching and research.

Ze Zhang
(CHU de Quebec, Universite Laval, Canada)

Dr. Ze Zhang received his B.Eng. and M.Eng. in 1982 and 1984 from Chengdu University of Science & Technology (now Sichuan University) and then a PhD degree in Experimental Medicine from Université Laval in 1993. After a postdoctoral training in Japan he returned to the Saint-François d’Assise Hospital Research Center in Quebec City in 1995 and later became a professor in the Department of Surgery Faculty of Medicine at Université Laval and a researcher in the Centre de recherche du CHU de Québec – Université Laval. His research interests include electrically conductive biomaterials, polymeric materials in cardiovascular implants, cellular activities in electrical field, in vitro and in vivo evaluation of biomaterials, etc. Dr. Zhang’s research has been funded by the Canadian Institutes of Health Research (CIHR), the Natural Sciences and Engineering Research Council of Canada (NSERC), le Fonds de la recherche en santé du Québec (FRSQ), and by industrial partners. He has more than one hundred fifty journal publications, co-edited “Conductive Polymers: Electrical Interactions in Cell Biology and Medicine” and several book chapters.

Nicolas L'Heureux
(Université de Bordeaux, France)

Nicolas L’Heureux holds a B.Sc. in Biochemistry, a M.Sc. in Immunology and Microbiology, and a Ph.D. in Molecular and Cell Biology from the Laval University in Quebec City. He was a post-doctoral fellow of the American Heart Association at the Bioengineering Department at University of California, San Diego. In 2000, he co-founded Cytograft Tissue Engineering, Inc. (San Francisco) where he held the position of Chief Scientific Officer for 15 years. In 2015, he returned to academia at the French National Institute of Health (Inserm), in the Laboratory for the Bioengineering of Tissues (BioTis – Unité 1026), embedded at the University of Bordeaux, where is currently Unit Director.

Dr. L’Heureux has been an early believer in the possibility of developing completely biological tissue engineering approaches to produce constructs with physiological biomechanical properties. At a time when synthetic scaffolds were seen as a defining part of any tissue engineered construct, he demonstrated that the cell-assembled extracellular matrix (CAM), produced by normal human cells in vitro, can be used to create completely biological, living, autologous and human tissues that display remarkable mechanical strength without the need for any exogenous scaffolding. During his years at Cytograft Tissue Engineering, Dr. L’Heureux has sought to accelerate the translation of this technology to the clinic. This effort has led to the first clinical use of tissue-engineered blood vessels under arterial pressure and demonstration on long-term durability. Clinical data have also shown the possibility of using allogeneic CAM. Current efforts focus on the development of textile-based approaches to assemble CAM yarn into blood vessels and other constructs for therapeutic applications.

He was the recipient of a chair from the Excellence Initiative of Université de Bordeaux (IdEx). He has recently been/is funded by the Fédération Française de Cardiologie, the Région Nouvelle-Aquitaine, the Fondation de la Recherche Médicale, an ERC Advanced, and an ERC POC grant among others. He recently co-founded Biovalve Therapeutics, a startup which received a 2023 I-Lab national innovation award.

Sanasam Yaiphabi
(Manipur University, India)

Currently pursuing PhD in the Department of Biochemistry, Manipur University, Canchipur, Imphal, Manipur, India. I have completed my graduation from Jyoti Nivas College, Bengaluru, India in 2016 and Master in Biochemistry from Manipur University with Governor's Gold Medal for First Class First in MSc.(Biochemistry), 2018. I have attended and presented papers in national seminars and conferences as part of my PhD journey. Life Member of the professional society - Indian Science Congress, Kolkata. My aim is to work hard with enthusiasm, to achieve excellent output in every work of the research area, for the satisfaction of my superiors as well as public, positively.

Guoping GUAN
(Donghua University, China)

Dr. Guan holds both his bachelor's and master's degrees from Southwest University, specializing in Veterinary Medicine and Cell Biology respectively. In 2009, he achieved his Ph.D. from Soochow University, focusing his research on silk fibroin-based biomaterials. Following his doctoral studies, Dr. Guan embarked on a two-year postdoctoral fellowship at Donghua University, ultimately transitioning to a faculty position which he has held to date. His unique blend of educational backgrounds has instilled in him a profound interest in the realm of biomedical textile materials.
Dr. Guan is a stalwart in the integration of diverse disciplines, devoting himself to talent nurturing, fostering innovation, and advancing entrepreneurship education and research across biology, medicine, textile science and engineering, materials science and engineering, and beyond. His remarkable contributions are evident in his extensive publication record, boasting over 100 research papers and more than 30 authorized invention patents, seven of which have been successfully commercialized by various companies.
As Editor-in-Chief or Co-Editor-in-Chief, Dr. Guan has authored or contributed to three esteemed books, including the first and second editions of "Biomedical Textiles" and "Tests and Evaluation of Biomedical Textiles." His aspirations extend beyond the classroom and laboratory, envisioning a future where he can cultivate a new generation of industry leaders with international perspectives and competitive edge in the field of biomedical textile materials. He aims to develop innovative medical devices that enhance human life and health, establish robust international collaborations, and embark on joint research projects that push the boundaries of scientific knowledge.

Hyung-Seop Han
(Center for Biomaterials/ Korea Insitute of Science and Technology, Korea, Republic of)

Hyung-Seop Han presently holds the position of Principal Research Scientist at the Center for Biomaterials, Korea Institute of Science and Technology (KIST). He successfully earned his Ph.D. degree in Musculoskeletal Sciences from the University of Oxford, UK, in 2019, during which he was affiliated with the Clarendon Scholars program. Dr. Han's research primarily revolves around translational studies, with recent accomplishments including the successful transition of medical hologram technology and condensation electrical stimulation systems to the private sector.

SangIhn Han
(Center for Biomaterials, Biomedical Research Division, Korea Institute of Science and Technology, Korea, Republic of)

SangIhn Han is currently a Senior Research Scientist at the Center for Biomaterials, Korea Institute of Science and Technology (KIST). He earned his Ph.D. in Chemical and Biological Engineering from Seoul National University in 2019, where he worked under the supervision of Professor Taeghwan Hyeon. Dr. Han's research focuses on the synthesis of inorganic nanomaterials and their applications in soft bioelectronics, as well as the development of nanozymes for treating diseases related to reactive oxygen species.

Diego Mantovani
(Department of Mining, Metallurgical and Materials Engineering/Laval University, Canada)

Professor in biomaterials, scientist in regenerative medicine, holder of the Canada Research Chair Tieur I in biomaterials and bioengineering for the innovation in surgery, Diego Mantovani is en expert in nanocoatings, biodegradable metals and 3D cell culture for advanced in vitro tests alternative to in vivo. With his team, he carried out R&D&I projects often in collaboration with companies to unravel how sciences and engineering can improve the patient quality of life of Humans, and to develop new processes for improving the clinical performances of commercial devices, as well as exploring new strategies for tomorrow's clinical therapies. Focus is on cardiac, peripheral, cerebral, dental and parenchymal tissue. The Lab is based at ULaval, in the beatiful nordic city of Quebec, labelled UNESCO treasure, in the French-living part of Canada. He was elected Fellow of the International Union of Societies of Biomaterials since 2012, of the American Society for Materials Intl since 2016, the American Institute of Medical Biological Engineering since 2019, and of the Canadian Academy of Engineering since 2020. He was executive Co-Chair of the 10th World Biomaterials Congress, held in Montréal, Canada, in 2016, May.

Yufeng Zheng
(School of Materials Science and Engineering/Peking University, China)

Dr. Yufeng Zheng, received his Ph.D in materials science from Harbin Institute of Technology, China in 1998. From 1998 to 2004, he was Assistant Professor (1998-2000), Associate Professor (2000-2003), Full Professor (2003-2004) at Harbin Institute of Technology, China. He has been a full professor at the Peking University in Beijing, China since 2004, and Distinguished Professor at Kumamoto University, Japan since 2017. Dr. Zheng has authored or co-authored over 700 scientific peer-reviewed articles, with the citation of over 40000 times, and a H-index of 100. Currently he serves as Editor-in-Chief of “Bioactive Materials”, Vice Editor-in-Chief of “Journal of Materials Science & Technology”, Editor of “Materials Letters”. His areas of special interest include the development of new metallic biomaterials and their medical devices (biodegradable Mg, Fe and Zn based alloys, beta-Ti alloys with low elastic modulus, bulk metallic glass, ultra-fine grained metallic materials, etc). Dr. Zheng is the Fellow of American Institute for Medical and Biological Engineering (AIMBE) and Fellow of Biomaterials Science and Engineering (FBSE) by the International Union of Societies for Biomaterials Science and Engineering.

Seung-Kyun Kang
(Materials Science and Engineering/Seoul National University, Korea, Republic of)

Seung‑Kyun Kang is an associate professor working in the Department of Materials Science and Engineering at Seoul National University (SNU), Republic of Korea, since 2022. He was an assistant professor in the Department of Materials Science and Engineering at SNU from 2019 to 2022, and in the Department of Bio and Brain Engineering at the Korea Advanced Institute of Science and Technology (KAIST), Republic of Korea, from 2017 to 2019. Kang obtained his BS and PhD degrees in materials science and engineering from SNU in 2006 and 2012, respectively. He was a postdoctoral researcher at the University of Illinois at Urbana-Champaign from 2012 to 2016 and at Northwestern University from 2016 to 2017. Kang can be reached by email at kskg7227@snu.ac.kr.

Zhentao Yu
(Jinan University, China)

Dr.ZhentaoYu, began to work in 1987, then have been working in North west Institute for Nonferrous Metal research for 27 years. And then moved to work in Jinan University since 2019. Held the post as assistant engineer, engineer, senior engineer, and senior engineer with Prof. grade mainly on novel light metal materials, process and surface modification etc., including alloy designing, melting and process, microstructure and properties, and also engineering application research etc. Have taken charge of and taken part in more than 40 scientific projects of international, national or other grade, received 13 awards of national or ministry grade, and have applied for100 national invention patents of China, and also have published 7 books and more than 260 papers since 1998. Recently undertaking the R & D novel biomedical Ti, Mg, Zn alloys materials, surface modification, metal-base composite, advanced manufacture (3D printing) and their products. In 2020, He has been duly elected Fellow of Biomaterials Science and Engineering (FBSE) from International Union of Societies for Biomaterials Science and Engineering (IUSBSE). In 2023, He has been duly elected first Fellow of the Chinese Society for Biomaterials .He have been the executive member of the council of Chinese Society for Biomaterials and other 10 memberships.

Dewei Zhao
(Affliated Zhongshan Hospital of Dalian University, China)

Biodegradable metallic materials

Jangho Kim
(Chonnam National University, Korea, Republic of)

Dr. Jangho Kim is a Professor of Convergence Biosystems Engineering at Chonnam National University. He also serves as a Director of BK21 FOUR Center for IT-Bio Convergence System Agriculture and a founder and CEO in NANOBIOSYSTEM, CO., LTD. He received the Ph.D. degrees in biosystems engineering from Seoul National University, South Korea. He also worked as a Research in the Thin Film & Charged Particles Research Laboratory at Department of Electrical and Computer Engineering, University of Illinois at Urbana-Champaign. His research interests include 1) micro/nanofabrication & biologically inspired engineering systems, 2) mechanobiology & tissue engineering, and 3) bio/agricultural nanotechnology. He has authored and co-authored more than 145 peer-reviewed journal publications and 25 issued or pending patents. He is an Associate Editor of Journal of Biosystems Engineering (Springer Nature), Frontiers in Cell and Developmental Biology (Frontiers), and IEEE Transactions on NanoBioscience (IEEE), and serves as a member of the editorial boards of several journals. Among the awards he has received are Young Scientist Award (Korean and Japan Society for Biomaterials), Tissue Engineering Young Investigator (Tissue Engineering Parts A, B, & C), Young Plenary Speaker (TERMIS-AP conference), Samsung HumanTech Paper Award (Samsung Electronics), Keynote Speaker (TERM STEM 2014), Promising Young Scientist (Bioengineering Division, Korean Society of Mechanical Engineers), Excellent Young Professor Award (Chonnam National University), and Outstanding Reviewer (Biomaterials, Elsevier).

Shaoyang Bi
(Tianjin University, China)

Bi Shaoyang, a doctoral student in the Department of Mechanics at Tianjin University, China. The research field is about numerical simulatioon of the orthodontic process, the constitutive models and material parameter identification of the periodontal ligament.

Chaojing Li
(Donghua University, China)

Dr. Chaojing Li is an Associate Professor at the College of Textiles, Donghua University. She received her PhD degree in Biomedical Textile and Technology from Donghua University. She is mainly engaged in the construction of textile-based biomedical materials and their structure-induced regeneration mechanism. She has published more than 40 SCI papers in Advanced Functional Materials, Advanced Healthcare Materials, and other academic journals, and applied for more than 20 national invention patents.

Eben Alsberg
(Departments of Biomedical Engineering, Mechanical & Industrial Engineering, Pharmacology and Regenerative Medicine, and Orthopaedic Surgery / University of Illinois Chicago, USA)

Eben Alsberg holds the Richard and Loan Hill Chair Professorship in the Departments of Biomedical Engineering, Orthopaedic Surgery, Pharmacology and Regenerative Medicine, and Mechanical and Industrial Engineering at the University of Illinois at Chicago, where he serves as Director of the Alsberg Stem Cell and Engineered Novel Therapeutics (ASCENT) Laboratory. He was previously a professor at Case Western Reserve University in the Departments of Biomedical Engineering and Orthopaedic Surgery from 2005-2018. He received his B.S.E. in Biomedical Engineering and also in Mechanical Engineering and Material Science, cum laude, from Duke University in 1994. He then went to graduate school at the University of Michigan, Ann Arbor, where he received an M.S.E. in Mechanical Engineering (1998), an M.S.E. in Biomedical Engineering (1998), and a Ph.D. in Biomedical Engineering (2002). Following his graduate studies, he was a Postdoctoral Research Fellow in the Vascular Biology Program at Harvard Medical School.

His laboratory focuses on engineering functional biologic replacements to repair damaged or diseased tissues in the body. Complex signals implicated in tissue morphogenesis, repair, and homeostasis are used as inspiration for the development of innovative biomaterials for tissue regeneration. Through the precise temporal and spatial presentation of soluble bioactive factors, mechanical forces, and biomaterial physical and biochemical properties, his lab aspires to create microenvironments that regulate cell gene expression and new tissue formation. He has co-authored >155 peer reviewed papers and book chapters, and his work has been recognized with the Tissue Engineering and Regenerative Medicine International Society Senior Scientist Award, the Biovalley Young Investigator Award from the Tissue Engineering Society International, the Ellison Medical Foundation New Scholar in Aging Award, the Crain’s Cleveland Business Forty Under 40 Award, the Technion Lady Davis Fellowship, a Visiting Professorship at Kyung Hee University, and election as fellow of the National Academy of Inventors (NAI), Tissue Engineering and Regenerative Medicine (TERM), the American Institute for Medical and Biological Engineering (AIMBE) and the Biomedical Engineering Society (BMES). His research has been funded by the NIH, DOD, NSF, the Ellison Medical Foundation, the Coulter Foundation, the Musculoskeletal Transplant Foundation, the State of Ohio and the AO Foundation. Alsberg has ~35 patents issued or pending in the field of tissue engineering. He has given >160 invited lectures around the world and is active in many professional societies.

Wei Sun
(State Key Laboratory for Modification of Chemical Fibers and Polymer Materials, College of Materials Science and Engineering, Donghua University, China)

Dr. Sun Wei, a young researcher at State Key Laboratory for Modification of Chemical Fibers and Polymer Materials, College of Materials Science and Engineering, Donghua University. He obtained his Ph.D. from Tongji University in 2019 under the supervision of Professor Wu Guangming. He joined Donghua University in October 2019 and his main research areas include the design and construction of functional conductive elastic materials, and 3D printing of biomaterials for medical applications. He has published a total of 25 SCI papers, with 15 papers as the first author/corresponding author in international academic journals such as ACS Nano, Theranostics, J. Mater. Chem. A, Adv. Electron. Mater., etc. One of his papers has been highly cited according to ESI. He has filed 7 invention patents in China, 5 of which have been granted. He is the principal investigator for 1 National Natural Science Foundation of China (NSFC) Young Scientist Fund, 2 sub-projects of the Ministry of Science and Technology's key research and development program, and 1 collaborative project with industry.

Chuan Yin
(Shanghai Ninth People's Hospital Affiliated Shanghai JiaoTong University School of Medicine, China)

Yin Chuan, Doctor of Clinical Medicine from Peking University. He has held various positions such as surgical resident, orthopedic attending physician, medical device R&D engineer, and CEO of a medical technology company. In 2021, he founded Beijing Surface Medical Technology Co., Ltd., completing the entrepreneurial process from 0 to 1 and has completed angel round financing.
Beijing Surface Medical Technology Co., Ltd. is dedicated to accelerating the post-operative recovery of orthopedic patients, with the integration of medical and engineering being its most distinctive feature. The core team consists of founding members from Peking University, Peking University Third Hospital, Institute of Semiconductors, Chinese Academy of Sciences, and Qilu Hospital of Shandong University.
Currently, Beijing Surface Medical Technology has developed five product lines, including a light-functionalized irradiator for spinal surgery implants, MAO calcium phosphate and vancomycin coatings, and vancomycin hydrogel. For instance, the light-functionalized irradiator for spinal surgery implants, based on immediate intraoperative surface modification technology, can effectively reduce the bone healing and recovery time post-surgery, and minimize the complications arising from prolonged bed rest, demonstrating high clinical and social value. Currently, the product has successfully completed pre-clinical trials and obtained global invention patents.

Michael Davis
(Emory University and Georgia Institute of Technology, USA)

Dr. Davis is a Professor and Associate Chair in the Wallace H. Coulter Department of Biomedical Engineering at Emory University and Georgia Institute of Technology. He is also the Director of the Children's Heart Research and Outcomes Center at Children's Healthcare of Atlanta. Dr. Davis's research focuses on cellular and biomaterial approaches to adult and pediatric cardiac repair.

Soah Lee
(Sungkyunkwan University, Korea, Republic of)

Dr. Lee is an Assistant Professor in the School of Pharmacy at Sungkyunkwan University. Her unique educational background and research training make her an outstanding interdisciplinary tissue engineer who can bridge the gap between biomaterials engineering, iPSC biology, and developmental biology. The ultimate goal of her research is to develop an in vitro microphysiological system that can revolutionize the drug development process by replacing conventional non-human disease-irrelevant models. To achieve this goal, she was dedicated to developing biomimetic biomaterials, studying biomaterial-cell interaction, and elucidating molecular mechanisms underlying cardiomyocyte proliferation and differentiation during her training, which led to 30+ peer-reviewed articles including high impact journals like Cell Stem Cell, Circulation, and Biomaterials. At SKKU, she is expanding her research horizon by developing disease-relevant high-throughput drug screening platform utilizing iPSC technology as well as bioprinting technology. Her excellence in research has been recognized by multiple awards including AHA 2022 BCVS Young Investigator Poster Awards and Manuscript Winner of 2016 Young Investigator Award of the Society for Biomaterials. Soah has also been a well-funded researcher supported by Stanford Bio-X, Stanford Child Health Research Institute, NIH in US, and Ministry of Education, Health and Wellfare, as well as Samsung in South Korea.

Daniel Heath
(University of Melbourne, Australia)

Dr Heath is an Associate Professor of Biomedical Engineering at The University of Melbourne, Australia. His lab focuses on biomaterials and tissue engineering research for a variety of applications, with specific focus on blood-contacting biomaterials, environments for MSC expansion, and antimicrobial nanomaterials.

Martin W. King
(North Carolina State University, USA)

Martin King joined the Wilson College of Textiles, North Carolina State University, as Professor of Biotextiles and Textile Technology in September 2000 following more than 30 years of experience working in industry, higher education, the healthcare and government sectors in Canada and Europe. After graduating in Polymer Technology from UMIST, Manchester, England, and receiving his PhD in Biomedical Engineering (Génie biologique) from l’Université de Technologie de Compiègne, France, he has worked as a product development engineer for Hoechst-Celanese in Canada and at the British Ministry of Technology developing novel carbon fibers for the reinforcement of plastic components in Rolls-Royce jet engines.
For over 40 years Martin King has pioneered research at the intersection of biomaterials, fiber and polymer science and textile engineering. Since 1972 he has been a faculty member at the University of Manitoba, Canada where he coined the term “Biotextiles” to refer to fiber-based implantable medical devices. During his academic career he has been a consultant with all the major medical device companies in the USA, and has been invited to establish biomedical textile laboratories in various countries around the globe. In 1981-83 he helped establish the Quebec Biomaterials Institute in le Département de Chirurgie (Department of Surgery) at Université Laval, Québec, Canada. Then in 2000 he was recruited to establish the first ever undergraduate university program in “Medical Textiles” at the Wilson College of Textiles at North Carolina State University. In 2005 he was appointed as the “Chaired Professor of Medical Textiles”, and the only non-Chinese faculty member, at Donghua University, Shanghai, China. More recently his unique expertise has been recognized in Ecuador and Pakistan where he has been invited to establish new university curricula and laboratory facilities for biomedical textile teaching and research.

Seeram Ramakrishna
(National University of Singapore, Singapore)

Professor Seeram Ramakrishna is a world-renowned scholar of cross-field at the National University of Singapore, which is ranked among the top 8 universities in the world. He is named among the World’s Most Influential Minds (Thomson Reuters); Top 1% Highly Cited Researchers in the world (Clarivate Analytics); and among the top 25 scientists in Nanoscience & Nanotechnology (Ioannidis | Stanford University c-score). His publications to date have an H-index of 186 and over 172,176 citations. He is advocating intelligent | living | sustainable biomedical materials. He is the Biomaterials Section Editor of Elsevier journal Current Research in Biomedical Engineering, and editorial board member of Elsevier Journal Biomaterials Advances. He is an Associate Editor of eScience journal, and Advanced Fiber Materials journal. He is an editor of RSC Soft Matter Series. He is an elected Fellow of American Association for Advancement of Science (AAAS); ASM International; ASME; AIMBE, USA; Royal Academy of Engineering (FREng), UK; Chinese Academy of Engineering; Indian National Academy of Engineering, Singapore Academy of Engineering. He is an elected Fellow of International Union of Societies of Biomaterials Science and Engineering (FBSE).

Fan Zhang
(University of Washington, USA)

Fan Zhang (she/her/hers) is a postdoctoral scholar at UW in the Department of Bioengineering. Fan received her Ph.D. degree in Fiber and Polymer Science under the direction of Dr. Martin King at North Carolina State University, engineering immunomodulatory biomaterials for tissue-engineered vascular graft. Her work bridges several facets of regenerative medicine, including biomaterial engineering, scaffold design, regenerative immunology and vascularization. Fan’s current research focuses on understanding the mechanism underlying biomaterial-induced vascularization and the vascularization of engineered tissue and organ.

R. Helen Zha
(Rensselaer Polytechnic Institute, USA)

Dr. Helen Zha received her B.Sc. (2007) from MIT and her Ph.D. (2013) from Northwestern University in Materials Science & Engineering. After pursuing postdoctoral research at Eindhoven University of Technology and UC Berkeley, Helen started as a tenure-track assistant professor at Rensselaer Polytechnic Institute in the Department of Chemical & Biological Engineering in 2018. Helen has received an NSF CAREER Award, published 26 peer-reviewed journal articles to date, and currently sits on the Scientific Advisory Board of Materials Innovation Initiative.

Yoon Ki Joung
(Korea Institute of Science and Technology, Korea, Republic of)

I am a scientist studying polymeric biomaterials and their surface functionalization and biointerfacial modulation.

Sung-Hwan Choi
(Yonsei University College of Dentistry, Korea, Republic of)

Prof. Sung-Hwan Choi's laboratory team engages in multi-disciplinary translational research, primarily concentrating on the development and testing of long-term biofouling-resistant polymers for biomedical applications. Leveraging previous expertise in material characterization, in vivo efficacy analysis (medium-size dog model) (ACS Nano 2021), and microbiological characterization, including metagenomic analysis of microbiota. Furthermore, Dr. Choi possesses broad experience in the biomaterial characterization of glass-based composites for dental tissue remineralization (Bioactive Materials, 2022) and metagenomic functional analysis of surface polymer interaction (Biomaterials 2023).

Shaoyi Jiang
(Cornell University, USA)

Shaoyi Jiang joined the Meinig School of Biomedical Engineering at Cornell as the Robert Langer ’70 Family and Friends Professor in June 2020. Before Cornell, he was the Boeing-Roundhill Professor of Engineering in the Department of Chemical Engineering and an adjunct professor of Bioengineering at the University of Washington, Seattle. He received his Ph.D. degree in chemical engineering from Cornell University in 1993. He was a postdoctoral fellow at the University of California, Berkeley between 1993 and 1994 and a research fellow at California Institute of Technology between 1994 and 1996 both in chemistry. He is currently a fellow of the American Association for the Advancement of Science (AAAS), a fellow of the American Institute of Chemical Engineers (AIChE), a fellow of the American Institute for Medical and Biological Engineering (AIMBE), an executive editor for Langmuir and an associate editor for Science Advances. He received the Braskem Award for Excellence in Materials Engineering and Science, AIChE (2017). His research focuses on biomaterials, particularly highly biocompatible and environmentally benign zwitterionic-based materials for biomedical and engineering applications.

César Rodriguez-Emmenegger
(DWI – Leibniz-Institut für Interaktive Materialien, Germany)

César Rodriguez-Emmenegger is a Research Professor at the Institute for Bioengineering of Catalonia (IBEC) and the Catalan Institute for Research and Advanced Studies (ICREA) in Barcelona, Spain. The overarching goal of his research is to uncover design rules to develop materials capable of communicating with living matter —pathogens, cells, tissues— and directing its behavior in a self-regulated manner to enable new biomaterials, therapeutics, and medical devices. He studied Chemical Engineer at Universidad de la República, Uruguay; and a PhD in Biophysics and Macromolecular Chemistry and Physics at the Institute of Macromolecular Chemistry in Prague under the mentorship of Eduard Brynda and Aldo Bologna Alles. Following a postdoctoral research at the group of Prof. C. Barner-Kowollik (Alexander von Humboldt postdoctoral fellowship, 2012-2013), and research stays in Melville Laboratory in Cambridge (Prof. W.T.S. Huck, 2009), University of Pennsylvania (Prof. V. Percec, 2013, 2015) and Pasteur Institute in Lille (Prof. Lafont, 2015), César returned to Prague to start his independent group supported by a Junior Grant from GACR. He was then a Junior Group Leader at DWI-Leibniz Institute for Interactive Materials in Aachen (2016 – 2022) before joining IBEC.

Sung-Hwan Choi
(Yonsei University College of Dentistry, Korea, Republic of)

Prof. Sung-Hwan Choi's laboratory team engages in multi-disciplinary translational research, primarily concentrating on the development and testing of long-term biofouling-resistant polymers for biomedical applications. Leveraging previous expertise in material characterization, in vivo efficacy analysis (medium-size dog model) (ACS Nano 2021), and microbiological characterization, including metagenomic analysis of microbiota. Furthermore, Dr. Choi possesses broad experience in the biomaterial characterization of glass-based composites for dental tissue remineralization (Bioactive Materials, 2022) and metagenomic functional analysis of surface polymer interaction (Biomaterials 2023).